Literature DB >> 809102

Ontogeny of multiple forms of monoamine oxidase in mouse brain.

F J Chordikian, B Tabakoff, S G Alivisatos.   

Abstract

MAO activities in mouse brain responsible for deamination of serotonin (5-HT) and p-dimethylaminobenzylamine (DAB) were found to follow different postnatal developmental patterns. MAO activity which deaminated 5-HT reached adult levels 15 days after birth. At this age the capacity of brain to deaminate DAB was only 50% of adult levels and did not develop fully until after the 45th postnatal day. Inhibitor studies with Deprenil and clorgyline indicated that the deamination of the two substrates was due to different forms of MAO and that these forms were similar to type A and type B MAO described previously in rat brain.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 809102     DOI: 10.1016/0006-8993(75)90352-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Genotype dependence of monoamine oxidase in inbred strains of mice.

Authors:  A D MacPike; H Meier
Journal:  Experientia       Date:  1976-08-15

2.  Brain regional distributions of monoamine oxidase activities in postnatal development in normal and chronically manganese-treated rats.

Authors:  T K Leung; L Lim; J C Lai
Journal:  Metab Brain Dis       Date:  1993-09       Impact factor: 3.584

3.  Monoamine oxidase in young and adult rat brain capillaries.

Authors:  P H Yu
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

4.  Developmental changes in the activity and substrate specificities of mouse brain monoamine oxidase.

Authors:  Y Koide; K Kobayashi
Journal:  Neurochem Res       Date:  1984-05       Impact factor: 3.996

5.  Ethanol inhibits the activity of the B form of monoamine oxidase in human platelet and brain tissue.

Authors:  B Tabakoff; J M Lee; F De Leon-Jones; P L Hoffman
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  Characteristics of enzymes forming 3-methoxy-4-hydroxyphenylethyleneglycol (MOPEG) in brain.

Authors:  R A Anderson; L R Meyerson; B Tabakoff
Journal:  Neurochem Res       Date:  1976-10       Impact factor: 3.996

7.  Developmental changes in human dopamine neurotransmission: cortical receptors and terminators.

Authors:  Debora A Rothmond; Cynthia S Weickert; Maree J Webster
Journal:  BMC Neurosci       Date:  2012-02-15       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.